Roger Barker, Professor of Clinical Neuroscience in Cambridge, has an international reputation for his contributions to the clinical science of neurodegeneration. He has combined innovative work on disease mechanisms in Parkinson’s and Huntington’s diseases with a thorough evaluation of clinical phenotype in these diseases. He is an advocate who brings extensive knowledge of clinical neurology, engagement with basic neuroscience and an ability to explain complex topics to audiences with all levels of sophistication. |He has been recognised for this by a personal professorship in Cambridge, co-chairmanship of the European Research Council neurosciences panel, and appointment as co-chief editor of the Journal of Neurology.|